Related Experiment Video
Updated: Jan 20, 2026

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
A Cyclic Pentamethinium Salt Induces Cancer Cell Cytotoxicity through Mitochondrial Disintegration and Metabolic
Radovan Krejcir1, Lucie Krcova2,3, Pavlina Zatloukalova1
1Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
Abstract:
Cancer cells preferentially utilize glycolysis for ATP production even in aerobic conditions (the Warburg effect) and adapt mitochondrial processes to their specific needs. Recent studies indicate that altered mitochondrial activities in cancer represent an actionable target for therapy. We previously showed that salt 1-3C, a quinoxaline unit (with cytotoxic activity) incorporated into a meso-substituted pentamethinium salt (with mitochondrial selectivity and fluorescence properties), displayed potent cytotoxic effects in vitro and in vivo, without significant toxic effects to normal tissues. Here, we investigated the cytotoxic mechanism of salt 1-3C compared to its analogue, salt 1-8C, with an extended side carbon chain. Live cell imaging demonstrated that salt 1-3C, but not 1-8C, is rapidly incorporated into mitochondria, correlating with increased cytotoxicity of salt 1-3C. The accumulation in mitochondria led to their fragmentation and loss of function, accompanied by increased autophagy/mitophagy. Salt 1-3C preferentially activated AMP-activated kinase and inhibited mammalian target of rapamycin (mTOR) signaling pathways, sensors of cellular metabolism, but did not induce apoptosis. These data indicate that salt 1-3C cytotoxicity involves mitochondrial perturbation and disintegration, and such compounds are promising candidates for targeting mitochondria as a weak spot of cancer.
Insights
Salt 1-3C, a novel compound, targets cancer cell mitochondria, causing their disintegration and inhibiting tumor growth. This targeted approach shows promise for cancer therapy with minimal harm to healthy tissues.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Cancer cells exhibit altered metabolism, notably the Warburg effect, and rely on mitochondria.
- Mitochondrial dysfunction in cancer presents a therapeutic vulnerability.
- Previous work established salt 1-3C as a potent anti-cancer agent with mitochondrial selectivity.
Purpose of the Study:
- To elucidate the cytotoxic mechanism of salt 1-3C in comparison to its analogue, salt 1-8C.
- To investigate the role of mitochondrial targeting in salt 1-3C's anti-cancer activity.
Main Methods:
- Live cell imaging to track compound localization.
- Assessment of mitochondrial morphology and function.
- Analysis of cellular signaling pathways, including AMP-activated kinase and mTOR.
- Evaluation of apoptosis and autophagy/mitophagy induction.
Main Results:
- Salt 1-3C rapidly accumulated in mitochondria, unlike salt 1-8C, correlating with higher cytotoxicity.
- Mitochondrial fragmentation, loss of function, and increased mitophagy were observed upon salt 1-3C treatment.
- Salt 1-3C activated AMP-activated kinase and inhibited mTOR signaling without inducing apoptosis.
Conclusions:
- Salt 1-3C exerts cytotoxicity through mitochondrial perturbation and disintegration.
- Targeting cancer cell mitochondria with compounds like salt 1-3C is a viable therapeutic strategy.
Related Concept Videos
11:11Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
05:21Assessing Antibody-dependent, Cell-mediated Cytotoxicity in Cancer Cells using Antibody-Dependent Cell-Mediated Cytotoxicity Reporter Bioassay
02:55An In Vitro Assay for Evaluating Natural Killer Cell Cytotoxicity against Cancer Cells
07:44Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture
08:15Exploring Mitochondrial Energy Metabolism of Single 3D Microtissue Spheroids Using Extracellular Flux Analysis
An Introduction to Cell Metabolism

